<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <title>PING</title>
  <link rel="icon" type="image/jpeg" href="Pics/Favicon.png">
  <link rel="stylesheet" href="styles.css">
</head>

<body>
  <header>
    <nav>
      <a href="#home">Home</a>
      <a href="#about">About</a>
      <a href="#events">Events</a>
      <a href="#contact">Contact</a>
    </nav>
  </header>
  <main>

    <section id="home" class="section">
      <h1>The Pneumococci & Pneumonia INnterest Group (PING)</h1>

      <p>
        PING is a interdisciplinary online network connecting researchers working pneumonia prevention and control from
        multiple angles.
      </p>

      <p>
        The network connects those with an interest in pneumococci and pneumonia and provides updates on recent and
        current research and other developments in the field. It is also designed to give early career researchers an
        opportunity to informally share their research, practice their presentation skills and get input from a range of
        experts
      </p>
    </section>

    <section id="about" class="section">
      <h2>About the Network</h2>
      <p>
        PING was established in 2019, with the aim of fostering collaboration and knowledge exchange among scientists
        working on pneumococci and pneumonia. The network is open to researchers from around the world who share an
        interest in these topics.
      </p>
      <p>
        We meet online every other month to discuss recent research findings, share updates on ongoing projects, and
        explore new ideas. Our meetings feature presentations members of the network, with a preference for early career
        researchers.
      </p>
    </section>

    <section id="events" class="section">
      <h2>Upcoming Events</h2>

      <div class="events-grid">
        <div class="event-card">
          <div class="event-date">March 2026</div>
          <div class="event-content">
            <p><strong>tbc:</strong> </p>
            <p><strong>tbc:</strong> </p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">April 2026</div>
          <div class="event-content">
            <p><strong>tbc</strong> </p>
            <p><strong>tbc</strong> </p>
          </div>
        </div>
      </div>


      <h2>Past Events</h2>

      <div id="past-events" class="events-grid collapsed">


        <div class="event-card">
          <img src="Pics/PING Jan 2026.png" alt="January 2026 preview" class="event-thumb">
          <div class="event-date">January 2026</div>
          <div class="event-content">
            <p><strong>Kate Mellor:</strong> Maternal & environmental influences on pneumococcal colonisation</p>
            <p><strong>Matej Kritznar:</strong> Inferring transmission direction from carriage studies</p>
          </div>
        </div>

        <div class="event-card">
          <img src="Pics/PING Nov 2025.png" alt="November 2025 preview" class="event-thumb">
          <div class="event-date">November 2025</div>
          <div class="event-content">
            <p><strong>John Ojal:</strong> PCV programme in Kenya</p>
            <p><strong>Julia Mayer:</strong> Nirsevimab benefit outside RSV season</p>
          </div>
        </div>

        <div class="event-card">
          <img src="Pics/PING Sept 2025.png" alt="September 2025 preview" class="event-thumb">
          <div class="event-date">September 2025</div>
          <div class="event-content">
            <p><strong>Stefan:</strong> Protection from a single PCV dose in the first year of life</p>
            <p><strong>David Hodgson:</strong> Antibody kinetics & CoPs for RSV</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">July 2025</div>
          <div class="event-content">
            <p><strong>David Hodgson:</strong> Antibody kinetics & CoPs for RSV</p>
            <p><strong>Kevin van Zandvoort:</strong> Early impact of a PCV campaign in a Somali refugee camp</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">April 2025</div>
          <div class="event-content">
            <p><strong>Isaac Osei:</strong> Identifying specific age-group reservoirs for persistent vaccine-type
              pneumococcal carriage in rural Gambia</p>
            <p><strong>Grant McKenzie:</strong> Effectiveness of reduced dose schedules to control pneumococcal carriage
              and disease in the Gambia, a cRCT</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">January 2025</div>
          <div class="event-content">
            <p><strong>Raymond:</strong> Understanding the invasiveness of pneumococcus using genomic data</p>
            <p><strong>Charles:</strong> Urine-based detection of pneumococcal serotype among hospitalised children with
              acute respiratory infections and high antibiotic exposure in Malawi</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">November 2024</div>
          <div class="event-content">
            <p><strong>Akuzike Kalizang'Oma:</strong> Three dose PCV schedules; a cRCT in Malawi</p>
            <p><strong>Kaiyuan Sun:</strong> RSV transmission in South African households</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">September 2024</div>
          <div class="event-content">
            <p><strong>Annabelle Wong:</strong> The association of post booster IgG response and vaccine efficacy
              against carriage in Israeli children</p>
            <p><strong>Ayaka Monoi:</strong> Benefit-risk analysis of maternal RSV vaccine in South Africa</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">June 2024</div>
          <div class="event-content">
            <p><strong>Kate:</strong> A global analysis of pneumococcal invasiveness</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">April 2024</div>
          <div class="event-content">
            <p><strong>John Ojal:</strong> Impact of the current, and of potential policy options of, PCV programme in
              Nigeria</p>
            <p><strong>Stefan Flasche:</strong> What to do with PCV20 in the EU?</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">February 2024</div>
          <div class="event-content">
            <p><strong>ISPPD pactise:</strong> Dam, Momodou, David</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">December 2023</div>
          <div class="event-content">
            <p><strong>Talks:</strong> </p>
            <p><strong>Yoon Choi:</strong> Potential impact of new higher valency PCVs in England – a mathematical
              modelling study</p>
            <p><strong>Harry Hung:</strong> A Portable and Scalable Genomic Analysis Pipeline for Streptococcus
              pneumoniae Surveillance: GPS Pipeline</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">September 2023</div>
          <div class="event-content">
            <p><strong>George Qian & Jane Metz:</strong> Pneumococcal density, the Live Attenuated Influenza Vaccine and
              Transmission of Streptococcus Pneumoniae in UK families (the TOP study)</p>
            <p><strong>Akuzike Kalizang'oma</strong> Intermediate results of a cRCT comparing 3p+0 and 2p+1 in Blantyre
              Malawi</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">July 2023</div>
          <div class="event-content">
            <p><strong>Akuzike Kalizang'oma:</strong> Azithromycin resistance in pneumococci in Malawi following the
              MODOR trial </p>
            <p><strong>Greg Barnsley:</strong> Considerations for MDAs with Azithromycin in acute phase humanitarian
              crises</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">May 2023</div>
          <div class="event-content">
            <p><strong>Kate Gallhager:</strong> The vaccine efficacy of fractional doses of PCV</p>
            <p><strong>Billy Quilty:</strong> An overview of the evidence on the ability of a reduced dose PCV schedules
              to control VT carriage</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">March 2023</div>
          <div class="event-content">
            <p><strong>Rasheed:</strong>Effect of a PCV booster dose on the density of VT pneumococcal carriage</p>
            <p><strong>Jada Hackmann:</strong> “Evaluating Methods for Identifying and Quantifying Streptococcus
              Pneumoniae Subpopulations Using Next-Generation Sequencing”</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">January 2023</div>
          <div class="event-content">
            <p><strong>Yicong L:</strong>Understanding the impact of pneumococcal conjugate vaccines on the spread of
              antibiotic resistance using phylogenetics </p>
            <p><strong>Nick C:</strong> NFDS models to predict the impact of switching to PCV15 or PCV20 in the UK</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">November 2022</div>
          <div class="event-content">
            <p><strong>Stephanie Lo:</strong> Genomic serotyping for pneumococcal carriage – are we there yet? </p>
            <p><strong>Billy Quilty:</strong> Non-inferiority of reduced dose pneumococcal schedules in Nha Trang,
              Vietnam </p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">September 2022</div>
          <div class="event-content">
            <p><strong>Megan Verma:</strong> Streptococcus pneumoniae carriage in 75 countries from the RESPICAR dataset
            </p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">June 2022</div>
          <div class="event-content">
            <p><strong>ISPPD preparation:</strong> George Quian, Dam Khan, Modupeh Betts, Katherine Gallagher</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">March 2022</div>
          <div class="event-content">
            <p><strong>Brenda:</strong> Widespread sharing of pneumococcal strains in a rural African setting: proximate
              villages are more likely to share similar strains that are carried at multiple timepoints</p>
            <p><strong>Aisha:</strong> Monitoring the post PCV disease burden in Nigeria through carriage surveys</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">January 2022</div>
          <div class="event-content">
            <p><strong>Deus Thindwa:</strong>Immunogenicity of alternative ten-valent pneumococcal conjugate vaccine
              schedules in infants in Ho Chi Minh City, Vietnam: results from a single-blind, parallel-group,
              open-label, randomised, controlled trial</p>
            <p><strong>Stephanie Lo:</strong> Decoding pneumococcal genomes to inform future vaccine design</p>
          </div>
        </div>

        <div class="event-card">
          <div class="event-date">November 2021</div>
          <div class="event-content">
            <p><strong>Tomoka Nakamura:</strong> Decline in pneumococcal disease in young children during the COVID-19
              pandemic associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal
              carriage: A prospective cohort study</p>
            <p><strong>Yang Liu:</strong> PCV uptake in the private market in China, a systematic review</p>
          </div>
        </div>

      </div>

      <div class="see-more-wrap">
        <button id="see-more-btn" class="see-more-btn" aria-expanded="false">See more</button>
      </div>

    </section>

    <section id="contact" class="section">
      <h2>Contact</h2>
      <p>If you wish to join the network please contact the <a href="mailto:stefan.flasche@charite.de">PING
          secretariat</a></p>
    </section>

  </main>
  <footer>
    <div class="footer-logo-wrap">
      <img src="Pics/Logo_PING.jpeg" alt="PING logo" class="footer-logo">
    </div>
    <div>© PING – Pneumococcal INterest Group</div>
  </footer>

  <script>
    document.addEventListener('DOMContentLoaded', function () {
      var past = document.getElementById('past-events');
      var btn = document.getElementById('see-more-btn');
      if (!past || !btn) return;
      var cards = past.querySelectorAll('.event-card');
      if (cards.length <= 6) {
        btn.style.display = 'none';
        return;
      }
      // ensure initial collapsed state
      if (!past.classList.contains('collapsed')) past.classList.add('collapsed');

      btn.addEventListener('click', function () {
        var expanded = past.classList.toggle('collapsed');
        if (expanded) {
          btn.textContent = 'See more';
          btn.setAttribute('aria-expanded', 'false');
        } else {
          btn.textContent = 'See less';
          btn.setAttribute('aria-expanded', 'true');
        }
      });
    });
  </script>

</body>

</html>